# OFS Capital Corp: overview

OFS · Nasdaq · CIK 1487918 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ofs.md) · [Financials](/companies/ofs/financials.md) · [Filings](/companies/ofs/filings.md) · [Insiders](/companies/ofs/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.27](/filings/0001487918-25-000108.md) | not reported | [(0.54)](/filings/0001487918-26-000054.md) | [(0.72)](/filings/0001487918-26-000078.md) | [0.22](/filings/0001487918-25-000108.md) | not reported | [(0.86)](/filings/0001487918-26-000054.md) | [0.42](/filings/0001487918-26-000078.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.00](/filings/0001487918-24-000006.md) | [1.37](/filings/0001487918-25-000009.md) | [(0.04)](/filings/0001487918-26-000021.md) | [2.12](/filings/0001487918-26-000021.md) | [(2.47)](/filings/0001487918-26-000021.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ofs/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Callodine Capital Management, LP](/funds/1741675.md) | 2026-06-30 | $380.0k | 107,346 |  | New +107,346 |
| [INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC](/funds/1818604.md) | 2026-06-30 | $352.2k | 98,647 |  | Reduced −11,301 |
| [Virtus Investment Advisers, LLC](/funds/19481.md) | 2026-06-30 | $319.3k | 90,189 |  | Reduced −2,476 |
| [Curi Capital, LLC](/funds/1332905.md) | 2026-06-30 | $230.1k | 65,000 |  | New +65,000 |
| [Vident Advisory, LLC](/funds/1744347.md) | 2026-06-30 | $147.9k | 41,780 |  | Reduced −7,457 |
| [Concorde Asset Management, LLC](/funds/1631773.md) | 2026-06-30 | $123.9k | 33,550 |  | Not compared |
| [O'SHAUGHNESSY ASSET MANAGEMENT, LLC](/funds/1423442.md) | 2026-06-30 | $123.3k | 34,826 |  | Reduced −26,355 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $97.6k | 27,562 |  | Reduced −12,001 |
| [Arkadios Wealth Advisors](/funds/1800798.md) | 2026-06-30 | $94.8k | 26,786 |  | Reduced −9,002 |
| [SOA Wealth Advisors, LLC.](/funds/1849444.md) | 2026-06-30 | $69.6k | 19,672 |  | Unchanged |

## Recent filings

[All 538 filings](/companies/ofs/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:31 ET | [8-K](/filings/0001487918-26-000090.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001487918-26-000090 |
| 2026-10-06 | 08:00 ET | [8-K](/filings/0001487918-26-000087.md) | 8.01 Other events | 0001487918-26-000087 |
| 2026-08-28 | 09:11 ET | [8-K](/filings/0001487918-26-000083.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001487918-26-000083 |
| 2026-08-11 | 16:36 ET | [8-K](/filings/0001487918-26-000080.md) | 8.01 Other events | 0001487918-26-000080 |
| 2026-07-31 | 17:32 ET | [10-Q](/filings/0001487918-26-000078.md) | Quarterly report, period 2026-06-30 | 0001487918-26-000078 |
| 2026-07-30 | 16:30 ET | [8-K](/filings/0001487918-26-000077.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001487918-26-000077 |
| 2026-06-10 | 11:34 ET | [8-K](/filings/0001487918-26-000061.md) | 5.07 Shareholder vote results | 0001487918-26-000061 |
| 2026-05-01 | 17:33 ET | [10-Q](/filings/0001487918-26-000054.md) | Quarterly report, period 2026-03-31 | 0001487918-26-000054 |
| 2026-04-30 | 16:31 ET | [8-K](/filings/0001487918-26-000053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001487918-26-000053 |
| 2026-04-29 | 10:39 ET | [DEF 14A](/filings/0001487918-26-000046.md) | Proxy statement, period 2026-06-10 | 0001487918-26-000046 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001487918-26-000021.md), filed Mar 3, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1487918
- Tickers: OFS, OFSSH, OFSSO
- Exchange: Nasdaq
- SIC code: not reported
- State of incorporation: not reported
- Filer category: Non-accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:32 ET. No prices; not investment advice.